ALK signs PRE-PEN supply contract with HealthTrust
HealthTrust will include the PRE-PEN skin test, used for the diagnosis of penicillin allergy, to help reduce the unnecessary use of toxic, broad spectrum antibiotics, which are known
The US Food and Drug Administration (FDA) has granted rare paediatric disease designation to Vanda Pharmaceuticals’ VCA-894A, an investigational antisense oligonucleotide therapy for Charcot-Marie-Tooth disease, axonal, type 2S (CMT2S).
The collaboration leverages Theraclone I-STAR technology, which is used to screen and identify novel human antibodies to pathogenic agents and endogenous therapeutic targets, to discover monoclonal antibodies against